Enzyme-Linked Immunosorbent Assay Testing Market by Test Type for Immunology, Inflammation, Infectious Diseases, Cancer, Protein Quantification and Other Applications: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

  • ID: 4531832
  • Report
  • Region: Global
  • 110 pages
  • Zion Market Research
1 of 3
The report covers forecast and analysis for the enzyme-linked immunosorbent assay (ELISA) testing market on a global and regional level. The study provides historic data of 2016 along with a forecast for 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the enzyme-linked immunosorbent assay (ELISA) testing market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the enzyme-linked immunosorbent assay (ELISA) testing market on a global level.

In order to give the users of this report a comprehensive view on the enzyme-linked immunosorbent assay (ELISA) testing market, we have to include competitive landscape and analysis of Porters Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein test type segments and application segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions mergers, new technology launch, agreements, partnerships, collaborations joint ventures, research development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

The study provides a decisive view on the enzyme-linked immunosorbent assay (ELISA) testing market by segmenting the market based on test type, application, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2014 to 2022. Based on test type the market is segmented into sandwich ELISA, indirect ELISA, multiple and portable ELISA and competitive ELISA. Key applications covered under this study include Immunology, inflammation, infectious diseases, cancer, protein quantification and others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East Africa with its further bifurcation into major countries including the U.S. Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for enzyme-linked immunosorbent assay (ELISA) testing based on individual test type and applications in all the regions and countries.

The report also includes detailed profiles of end players such as Thermo Fisher Scientific. Inc., American Laboratory Products Company (ALPCO), BD Biosciences, Bio-Rad Laboratories, Inc., BioMrieux, Ortho-Clinical Diagnostics, Inc., R D Systems Inc. and ZEUS Scientific, Inc. among others.

This report segments the global enzyme-linked immunosorbent assay (ELISA) testing market as follows:

Global Enzyme-linked immunosorbent assay (ELISA) testing Market: Test Type Segment Analysis:
Sandwich ELISA
Indirect ELISA
Multiple and portable ELISA
Competitive ELISA

Global Enzyme-linked immunosorbent assay (ELISA) testing Market: Application Segment Analysis:
Immunology
Inflammation
Infectious diseases
Cancer
Protein quantification
Others

Global Enzyme-linked immunosorbent assay (ELISA) testing Market: Regional Segment Analysis:
North America
U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Introduction
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology

2. Executive Summary
2.1. Global enzyme-linked immunosorbent assay (ELISA) testing market, 2016 2022 (USD Million)
2.2. Global enzyme-linked immunosorbent assay (ELISA) testing market : Snapshot

3. Enzyme-linked immunosorbent assay (ELISA) testing Market Dynamics
3.1. Introduction
3.2. Market drivers
3.2.1. Global enzyme-linked immunosorbent assay (ELISA) testing market drivers: Impact analysis
3.2.2. Emergence of cost effective technologies and laboratory automation for ELISA assay
3.2.3. Increasing research and development on biomarkers and monoclonal antibodies (mABs)
3.3. Market restraints
3.3.1. Global enzyme-linked immunosorbent assay (ELISA) testing market restraints: Impact analysis
3.3.2. Threat of substitution by new technologies
3.4. Opportunities
3.4.1. Increasing need for accurate and early disease diagnosis
3.5. Porters five forces analysis
3.5.1. Bargaining power of suppliers
3.5.2. Bargaining power of buyers
3.5.3. Threat from new entrants
3.5.4. Threat from new substitutes
3.5.5. Degree of competition
3.6. Market attractiveness analysis
3.6.1. Market attractiveness analysis, by test type segment
3.6.2. Market attractiveness analysis, by application segment
3.6.3. Market attractiveness analysis, by regional segment

4. Global Enzyme-linked immunosorbent assay (ELISA) testing Market Competitive Landscape
4.1. Company Market Share Analysis
4.1.1. Global enzyme-linked immunosorbent assay (ELISA) testing market: company market share, 2016
4.2. Strategic Development
4.2.1. Acquisitions Mergers
4.2.2. New Therapy Launch
4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
4.2.4. Research and Development, Therapy and Regional Expansion
4.3. Price Trend Analysis
4.4. Technology Portfolio

5. Global Enzyme-linked immunosorbent assay (ELISA) testing Market Test Type Segment Analysis
5.1. Global enzyme-linked immunosorbent assay (ELISA) testing market: Test Type overview
5.1.1. Global enzyme-linked immunosorbent assay (ELISA) testing market revenue share, by Test Type, 2016 and 2022
5.2. Sandwich ELISA
5.2.1. Global Sandwich ELISA market , 2016 2022(USD Million)
5.3. Indirect ELISA
5.3.1. Global Indirect ELISA market , 2016 2022(USD Million)
5.4. Multiple and portable ELISA
5.4.1. Global Multiple and portable ELISA market , 2016 2022(USD Million)
5.5. Competitive ELISA
5.5.1. Global Competitive ELISA market , 2016 2022(USD Million)

6. Global Enzyme-linked immunosorbent assay (ELISA) testing Market Application Segment Analysis
6.1. Global enzyme-linked immunosorbent assay (ELISA) testing market: Application overview
6.1.1. Global enzyme-linked immunosorbent assay (ELISA) testing market revenue share, by Application, 2016 and 2022
6.2. Immunology
6.2.1. Global enzyme-linked immunosorbent assay (ELISA) testing market for Immunology, 2016 2022 (USD Million)
6.3. Inflammation
6.3.1. Global enzyme-linked immunosorbent assay (ELISA) testing market for Inflammation, 2016 2022(USD Million)
6.4. Infectious diseases
6.4.1. Global enzyme-linked immunosorbent assay (ELISA) testing market for Infectious diseases, 2016 2022 (USD Million)
6.5. Cancer
6.5.1. Global enzyme-linked immunosorbent assay (ELISA) testing market for Cancer, 2015 - 2021(USD Million)
6.6. Protein quantification
6.6.1. Global enzyme-linked immunosorbent assay (ELISA) testing market for Protein quantification, 2015 - 2021(USD Million)
6.7. Others
6.7.1. Global enzyme-linked immunosorbent assay (ELISA) testing market for other applications , 2016 2022 (USD Million)

7. Global Enzyme-linked immunosorbent assay (ELISA) testing Market Regional Segment Analysis
7.1. Global enzyme-linked immunosorbent assay (ELISA) testing market: Regional overview
7.1.1. Global enzyme-linked immunosorbent assay (ELISA) testing market revenue share, by region, 2016 and 2022
7.2. North America
7.2.1. North America enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022 (USD Million)
7.2.2. North America enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022 (USD Million)
7.2.3. U.S.
7.2.3.1. U.S. enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022(USD Million)
7.2.3.2. U.S. enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022(USD Million)
7.3. Europe
7.3.1. Europe enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022(USD Million)
7.3.2. Europe enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022(USD Million)
7.3.3. Germany
7.3.3.1. Germany enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022(USD Million)
7.3.3.2. Germany enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022(USD Million)
7.3.4. France
7.3.4.1. France enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022(USD Million)
7.3.4.2. France enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022(USD Million)
7.3.5. UK
7.3.5.1. UK enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022(USD Million)
7.3.5.2. UK enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022(USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022, (USD Million)
7.4.2. Asia Pacific enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022, (USD Million)
7.4.3. China
7.4.3.1. China enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022(USD Million)
7.4.3.2. China enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022(USD Million)
7.4.4. Japan
7.4.4.1. Japan enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022(USD Million)
7.4.4.2. Japan enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022(USD Million)
7.4.5. India
7.4.5.1. India enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022(USD Million)
7.4.5.2. India enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022(USD Million)
7.5. Latin America
7.5.1. Latin America enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022(USD Million)
7.5.2. Latin America enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022(USD Million)
7.5.3. Brazil
7.5.3.1. Brazil enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022(USD Million)
7.5.3.2. Brazil enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022 (USD Million)
7.6.2. Middle East and Africa enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022 (USD Million)

8. Company Profile
8.1. Thermo Fisher Scientific. Inc.
8.1.1. Overview
8.1.2. Financials
8.1.3. Therapy portfolio
8.1.4. Business strategy
8.1.5. Recent developments
8.2. American Laboratory Products Company (ALPCO)
8.2.1. Overview
8.2.2. Financials
8.2.3. Therapy portfolio
8.2.4. Business strategy
8.2.5. Recent developments
8.3. BD Biosciences
8.3.1. Overview
8.3.2. Financials
8.3.3. Therapy portfolio
8.3.4. Business strategy
8.3.5. Recent developments
8.4. Bio-Rad Laboratories, Inc.
8.4.1. Overview
8.4.2. Financials
8.4.3. Therapy portfolio
8.4.4. Business strategy
8.4.5. Recent developments
8.5. BioMrieux
8.5.1. Overview
8.5.2. Financials
8.5.3. Therapy portfolio
8.5.4. Business strategy
8.5.5. Recent developments
8.6. Ortho-Clinical Diagnostics, Inc.
8.6.1. Overview
8.6.2. Financials
8.6.3. Therapy portfolio
8.6.4. Business strategy
8.6.5. Recent developments
8.7. R D Systems Inc.
8.7.1. Overview
8.7.2. Financials
8.7.3. Therapy portfolio
8.7.4. Business strategy
8.7.5. Recent developments
8.8. ZEUS Scientific, Inc.
8.8.1. Overview
8.8.2. Financials
8.8.3. Therapy portfolio
8.8.4. Business strategy
8.8.5. Recent developments
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll